Yvonne Greenstreet

Companies

• Alnylam PharmaceuticalsBoard member Jan 4, 2022 to now¹
• Alnylam PharmaceuticalsChief executive officer Jan 4, 2022 to now¹
• Pacira BioSciences, Inc.Board member Mar 6, 2014 to Jun 8, 2022²
• Alnylam PharmaceuticalsPresident Jan 13, 2021 to Dec 23, 2021³
• Alnylam PharmaceuticalsChief operating officer Sep 21, 2016 to Dec 23, 2021⁴
• Moelis & CompanyBoard member Feb 19, 2015 to Nov 16, 2018⁵
• Alnylam PharmaceuticalsEVP, Chief Commercial Officer Dec 22, 2016 to Dec 22, 2016⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Alnylam Pharmaceuticals ALNY96,209 shares⁷$22.7M at $235.58Sep 22, 2026
• PBPacira BioSciences, Inc. PCRX13,247 shares⁸$481.7K at $36.36Jun 8, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 19, 2026Granted 107 shares of Alnylam Pharmaceuticals⁷
• Mar 4, 2026Sold 265 shares at $325.67 of Alnylam Pharmaceuticals⁹
• Mar 4, 2026Sold 345 shares at $324.88 of Alnylam Pharmaceuticals⁹
• Mar 4, 2026Sold 973 shares at $323.84 of Alnylam Pharmaceuticals⁹
• Mar 4, 2026Sold 444 shares at $323.01 of Alnylam Pharmaceuticals⁹
• Mar 4, 2026Sold 368 shares at $321.82 of Alnylam Pharmaceuticals⁹
• Mar 4, 2026Sold 274 shares at $320.81 of Alnylam Pharmaceuticals⁹
• Mar 4, 2026Sold 129 shares at $320.01 of Alnylam Pharmaceuticals⁹
• Mar 4, 2026Sold 135 shares at $319.03 of Alnylam Pharmaceuticals⁹
• Mar 2, 2026Sold 160 shares at $332.64 of Alnylam Pharmaceuticals¹⁰
• Mar 2, 2026Sold 399 shares at $331.93 of Alnylam Pharmaceuticals¹⁰
• Mar 2, 2026Sold 346 shares at $330.85 of Alnylam Pharmaceuticals¹⁰
• Mar 2, 2026Sold 722 shares at $329.71 of Alnylam Pharmaceuticals¹⁰
• Mar 2, 2026Sold 424 shares at $328.71 of Alnylam Pharmaceuticals¹⁰
• Mar 2, 2026Sold 1,399 shares at $327.67 of Alnylam Pharmaceuticals¹⁰
• Mar 2, 2026Sold 1,669 shares at $326.81 of Alnylam Pharmaceuticals¹⁰
• Mar 2, 2026Sold 1,098 shares at $325.63 of Alnylam Pharmaceuticals¹⁰
• Mar 2, 2026Sold 382 shares at $324.65 of Alnylam Pharmaceuticals¹⁰
• Mar 2, 2026Sold 200 shares at $323.62 of Alnylam Pharmaceuticals¹⁰
• Mar 2, 2026Granted 13,844 shares of Alnylam Pharmaceuticals¹⁰
• Feb 27, 2026Exercised options 5,921 shares of Alnylam Pharmaceuticals¹¹
• Feb 13, 2026Sold 6,958 shares at $310.08 of Alnylam Pharmaceuticals¹²
• Feb 12, 2026Granted 14,209 shares of Alnylam Pharmaceuticals¹²
• Jan 12, 2026Sold 94 shares at $377.82 of Alnylam Pharmaceuticals¹³
• Jan 12, 2026Sold 118 shares at $375.65 of Alnylam Pharmaceuticals¹³